Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.
Kastritis E, Terpos E, Evangelakou Z, Theodorakakou F, Fotiou D, Manola MS, Gianniou DD, Bagratuni T, Kanellias N, Migkou M, Gavriatopoulou M, Trougakos IP, Dimopoulos MA. Kastritis E, et al. Among authors: theodorakakou f. Am J Hematol. 2022 Jan 1;97(1):E27-E31. doi: 10.1002/ajh.26406. Epub 2021 Nov 23. Am J Hematol. 2022. PMID: 34778995 Free PMC article. Clinical Trial. No abstract available.
Solid Organ Transplantation in Amyloidosis.
Theodorakakou F, Fotiou D, Dimopoulos MA, Kastritis E. Theodorakakou F, et al. Acta Haematol. 2020;143(4):352-364. doi: 10.1159/000508262. Epub 2020 Jun 12. Acta Haematol. 2020. PMID: 32535598 Free article. Review.
Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Fotiou D, Migkou M, Eleutherakis-Papaiakovou E, Kanellias N, Roussou M, Dialoupi I, Malandrakis P, Theodorakakou F, Kastritis E, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: theodorakakou f. Hemasphere. 2020 May 21;4(3):e381. doi: 10.1097/HS9.0000000000000381. eCollection 2020 Jun. Hemasphere. 2020. PMID: 32647800 Free PMC article. No abstract available.
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis.
Kastritis E, Fotiou D, Theodorakakou F, Dialoupi I, Migkou M, Roussou M, Karatrasoglou EA, Tselegkidi MI, Ntalianis A, Kanellias N, Eleutherakis-Papaiakovou E, Ntanasis-Stathopoulos I, Gakiopoulou C, Papanikolaou A, Papathoma A, Spyropoulou-Vlachou M, Psimenou E, Stamatelopoulos K, Gavriatopoulou M, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: theodorakakou f. Amyloid. 2021 Mar;28(1):3-11. doi: 10.1080/13506129.2020.1798224. Epub 2020 Jul 27. Amyloid. 2021. PMID: 32713209
Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause.
Kastritis E, Kanellias N, Theodorakakou F, Psimenou E, Gakiopoulou C, Marinaki S, Roussou M, Gavriatopoulou M, Migkou M, Fotiou D, Eleutherakis-Papaiakovou E, Malandrakis P, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: theodorakakou f. Leuk Lymphoma. 2020 Dec;61(13):3247-3250. doi: 10.1080/10428194.2020.1797013. Epub 2020 Jul 27. Leuk Lymphoma. 2020. PMID: 32716220 No abstract available.
Next generation flow cytometry for MRD detection in patients with AL amyloidosis.
Kastritis E, Kostopoulos IV, Theodorakakou F, Fotiou D, Gavriatopoulou M, Migkou M, Tselegkidi MI, Roussou M, Papathoma A, Eleutherakis-Papaioakovou E, Dialoupi I, Kanellias N, Ntalianis A, Rousakis P, Trougakos IP, Tsitsilonis O, Gakiopoulou C, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: theodorakakou f. Amyloid. 2021 Mar;28(1):19-23. doi: 10.1080/13506129.2020.1802713. Epub 2020 Aug 12. Amyloid. 2021. PMID: 32783569
Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance.
Kastritis E, Theodorakakou F, Roussou M, Psimenou E, Gakiopoulou C, Marinaki S, Gatou A, Fotiou D, Migkou M, Kanellias N, Eleutherakis-Papaiakovou E, Malandrakis P, Dialoupi I, Ntanasis-Stathopoulos I, Kostopoulos IV, Terpos E, Gavriatopoulou M, Dimopoulos MA. Kastritis E, et al. Among authors: theodorakakou f. Br J Haematol. 2021 Apr;193(1):113-118. doi: 10.1111/bjh.17052. Epub 2020 Aug 23. Br J Haematol. 2021. PMID: 32829529 Free article.
Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis.
Kastritis E, Terpos E, Sklirou A, Theodorakakou F, Fotiou D, Papanagnou ED, Bagratuni T, Kanellias N, Gavriatopoulou M, Trougakos IP, Dimopoulos MA. Kastritis E, et al. Among authors: theodorakakou f. Hemasphere. 2021 Jul 15;5(8):e614. doi: 10.1097/HS9.0000000000000614. eCollection 2021 Aug. Hemasphere. 2021. PMID: 34278231 Free PMC article. No abstract available.
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.
Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Papanagnou ED, Migkou M, Theodorakakou F, Roussou M, Eleutherakis-Papaiakovou E, Kanellias N, Trougakos IP, Kastritis E, Dimopoulos MA. Terpos E, et al. Among authors: theodorakakou f. Blood Cancer J. 2021 Aug 2;11(8):138. doi: 10.1038/s41408-021-00530-3. Blood Cancer J. 2021. PMID: 34341335 Free PMC article.
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease.
Kastritis E, Rousakis P, Kostopoulos IV, Gavriatopoulou M, Theodorakakou F, Fotiou D, Dialoupi I, Migkou M, Roussou M, Kanellias N, Tselegkidi MI, Eleutherakis-Papaiakovou E, Papanikolaou A, Gakiopoulou C, Psimenou E, Spyropoulou-Vlachou M, Gatou A, Terpos E, Tsitsilonis O, Dimopoulos MA. Kastritis E, et al. Among authors: theodorakakou f. Amyloid. 2021 Dec;28(4):259-266. doi: 10.1080/13506129.2021.1971192. Epub 2021 Sep 1. Amyloid. 2021. PMID: 34468250
49 results